Leishmania infantum leishmaniasis in corticosteroid-treated patients

Silvia Pittalis, Emanuele Nicastri, Francesco Spinazzola, Piero Ghirga, Michele De Marco, Maria Grazia Paglia, Pasquale Narciso

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: The number of leishmaniasis cases associated with immunosuppression has increased regularly over the past 20 years. Immunosuppression related to HIV infection, immunosuppressive treatment, organ transplantation, and neoplastic diseases increases the risk for Leishmania-infected people to develop visceral illness. Case presentation: Three cases of Leishmania infantum leishmaniasis in corticosteroid (CS)-treated patients are reported: an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS. Conclusion: Physicians should recognise CS-treated patients as a population likely to be immunesuppressed. In immunodeficiency conditions, unusual forms of leishmaniasis can develop and foster the risk of a diagnostic delay and of poor response to therapy.

Original languageEnglish
Article number177
JournalBMC Infectious Diseases
Volume6
DOIs
Publication statusPublished - 2006

Fingerprint

Leishmania infantum
Leishmaniasis
Adrenal Cortex Hormones
Immunosuppression
Cutaneous Leishmaniasis
Visceral Leishmaniasis
Leishmania
Myasthenia Gravis
Organ Transplantation
Immunosuppressive Agents
Tongue
HIV Infections
Asthma
Physicians
Skin
Therapeutics
Population

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Leishmania infantum leishmaniasis in corticosteroid-treated patients. / Pittalis, Silvia; Nicastri, Emanuele; Spinazzola, Francesco; Ghirga, Piero; De Marco, Michele; Paglia, Maria Grazia; Narciso, Pasquale.

In: BMC Infectious Diseases, Vol. 6, 177, 2006.

Research output: Contribution to journalArticle

@article{b4dd1d5c4cfc43aeaf8988602eb488d6,
title = "Leishmania infantum leishmaniasis in corticosteroid-treated patients",
abstract = "Background: The number of leishmaniasis cases associated with immunosuppression has increased regularly over the past 20 years. Immunosuppression related to HIV infection, immunosuppressive treatment, organ transplantation, and neoplastic diseases increases the risk for Leishmania-infected people to develop visceral illness. Case presentation: Three cases of Leishmania infantum leishmaniasis in corticosteroid (CS)-treated patients are reported: an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS. Conclusion: Physicians should recognise CS-treated patients as a population likely to be immunesuppressed. In immunodeficiency conditions, unusual forms of leishmaniasis can develop and foster the risk of a diagnostic delay and of poor response to therapy.",
author = "Silvia Pittalis and Emanuele Nicastri and Francesco Spinazzola and Piero Ghirga and {De Marco}, Michele and Paglia, {Maria Grazia} and Pasquale Narciso",
year = "2006",
doi = "10.1186/1471-2334-6-177",
language = "English",
volume = "6",
journal = "BMC Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Leishmania infantum leishmaniasis in corticosteroid-treated patients

AU - Pittalis, Silvia

AU - Nicastri, Emanuele

AU - Spinazzola, Francesco

AU - Ghirga, Piero

AU - De Marco, Michele

AU - Paglia, Maria Grazia

AU - Narciso, Pasquale

PY - 2006

Y1 - 2006

N2 - Background: The number of leishmaniasis cases associated with immunosuppression has increased regularly over the past 20 years. Immunosuppression related to HIV infection, immunosuppressive treatment, organ transplantation, and neoplastic diseases increases the risk for Leishmania-infected people to develop visceral illness. Case presentation: Three cases of Leishmania infantum leishmaniasis in corticosteroid (CS)-treated patients are reported: an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS. Conclusion: Physicians should recognise CS-treated patients as a population likely to be immunesuppressed. In immunodeficiency conditions, unusual forms of leishmaniasis can develop and foster the risk of a diagnostic delay and of poor response to therapy.

AB - Background: The number of leishmaniasis cases associated with immunosuppression has increased regularly over the past 20 years. Immunosuppression related to HIV infection, immunosuppressive treatment, organ transplantation, and neoplastic diseases increases the risk for Leishmania-infected people to develop visceral illness. Case presentation: Three cases of Leishmania infantum leishmaniasis in corticosteroid (CS)-treated patients are reported: an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS. Conclusion: Physicians should recognise CS-treated patients as a population likely to be immunesuppressed. In immunodeficiency conditions, unusual forms of leishmaniasis can develop and foster the risk of a diagnostic delay and of poor response to therapy.

UR - http://www.scopus.com/inward/record.url?scp=33846479400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846479400&partnerID=8YFLogxK

U2 - 10.1186/1471-2334-6-177

DO - 10.1186/1471-2334-6-177

M3 - Article

C2 - 17176478

AN - SCOPUS:33846479400

VL - 6

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

M1 - 177

ER -